StockData
Scienture Holdings, Inc. logo

Scienture Holdings, Inc. (SCNX) stock

SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$2.90−0.11 (-3.65%)

Close on Nov 13, 2026Market cap $119.09MP/E –Yield –

Scienture ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$42.10M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$42.10M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.24M–
Q1 FY2026Mar 31, 2026-$3.06M–
Q3 FY2016Sep 30, 2016-$238.72K–

More Scienture figures

See a number that looks wrong?